- Synecor LLC
- Duke University
- Guidant Corp.
- Advanced Cardiovascular Systems Inc.
- Stanford University
- Eli Lilly & Co.
- Ventritex Inc.
- St. Jude Medical Inc.
- Cardiac Pathways Corp.
- Boston Scientific Corp.
- Becton Dickinson & Co.
- BaroSense Inc.
- InnerPulse Inc.
- Mitralign Inc.
- Johnson & Johnson
- Abbott Laboratories Inc.
- Cameron Health Inc.
- Medtronic PLC
- Stryker Corp.
- Zimmer Biomet Holdings Inc.
- Novartis AG
- Biosensors International Group Ltd.
- NDO Surgical Inc.
- EndoGastric Solutions Inc.
- Boston Scientific acquires Cardiac Pathways
- SyneCor, new CV device incubator, raises $10.5mm
- Interventional Rhythm Management gets $15.1mm in Series A round
- J&J withdraws offer to acquire Guidant
- Boston Scientific wins $27bn bid for Guidant
- Abbott acquires Guidant's vascular business
- Guidant gets co-exclusive rights to Novartis antibiotic
- Guidant to license Biosensors' drug-eluting stents
Ask The Analyst
Ask the Analyst is free for subscribers. Submit your question and one of our analysts will be in touch.
Your question has been successfully sent to the email address below and we will get back as soon as possible. firstname.lastname@example.org.
All fields are required.
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.